Literature DB >> 31066093

A conditional error function approach for adaptive enrichment designs with continuous endpoints.

Marius Placzek1, Tim Friede1,2.   

Abstract

Adaptive enrichment designs offer an efficient and flexible way to demonstrate the efficacy of a treatment in a clinically defined full population or in, eg, biomarker-defined subpopulations while controlling the family-wise Type I error rate in the strong sense. Frequently used testing strategies in designs with two or more stages include the combination test and the conditional error function approach. Here, we focus on the latter and present some extensions. In contrast to previous work, we allow for multiple subgroups rather than one subgroup only. For nested as well as nonoverlapping subgroups with normally distributed endpoints, we explore the effect of estimating the variances in the subpopulations. Instead of using a normal approximation, we derive new t-distribution-based methods for two different scenarios. First, in the case of equal variances across the subpopulations, we present exact results using a multivariate t-distribution. Second, in the case of potentially varying variances across subgroups, we provide some improved approximations compared to the normal approximation. The performance of the proposed conditional error function approaches is assessed and compared to the combination test in a simulation study. The proposed methods are motivated by an example in pulmonary arterial hypertension.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adaptive design; enrichment; interim analysis; multiple testing; subgroup analysis

Mesh:

Substances:

Year:  2019        PMID: 31066093     DOI: 10.1002/sim.8154

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection.

Authors:  Cynthia Huber; Tim Friede; Julia Stingl; Norbert Benda
Journal:  Ther Innov Regul Sci       Date:  2021-11-28       Impact factor: 1.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.